STAT Plus: Pharmalittle: NIH to test blood thinners against Covid-19; AbbVie employees feel pressured to return to work
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our
STAT+: Pharmalittle: We’re Reading About Amylyx Pulling Its ALS Drug, GLP-1 Drugs For Parkinson’s, And More
Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease.
